Science Advances,
Journal Year:
2022,
Volume and Issue:
8(12)
Published: March 25, 2022
Exosomes
are
extracellular
vesicles
of
endosomal
origin
that
released
by
practically
all
cell
types
across
metazoans.
active
vehicles
intercellular
communication
and
can
transfer
lipids,
RNAs,
proteins
between
different
cells,
tissues,
or
organs.
Here,
we
describe
a
mechanism
whereby
containing
KFERQ
motif
pentapeptide
loaded
into
subpopulation
exosomes
in
process
is
dependent
on
the
membrane
protein
LAMP2A.
Moreover,
demonstrate
this
independent
ESCRT
machinery
but
HSC70,
CD63,
Alix,
Syntenin-1,
Rab31,
ceramides.
We
show
master
regulator
hypoxia
HIF1A
to
transport
signaling
normoxic
cells.
In
addition,
tagging
fluorescent
with
KFERQ-like
sequences,
were
able
follow
interorgan
exosomes.
Our
findings
open
new
avenues
for
exosome
engineering
allowing
loading
bioactive
them
motifs.
Journal of Extracellular Vesicles,
Journal Year:
2024,
Volume and Issue:
13(2)
Published: Feb. 1, 2024
Extracellular
vesicles
(EVs),
through
their
complex
cargo,
can
reflect
the
state
of
cell
origin
and
change
functions
phenotypes
other
cells.
These
features
indicate
strong
biomarker
therapeutic
potential
have
generated
broad
interest,
as
evidenced
by
steady
year-on-year
increase
in
numbers
scientific
publications
about
EVs.
Important
advances
been
made
EV
metrology
understanding
applying
biology.
However,
hurdles
remain
to
realising
EVs
domains
ranging
from
basic
biology
clinical
applications
due
challenges
nomenclature,
separation
non-vesicular
extracellular
particles,
characterisation
functional
studies.
To
address
opportunities
this
rapidly
evolving
field,
International
Society
for
Vesicles
(ISEV)
updates
its
'Minimal
Information
Studies
Vesicles',
which
was
first
published
2014
then
2018
MISEV2014
MISEV2018,
respectively.
The
goal
current
document,
MISEV2023,
is
provide
researchers
with
an
updated
snapshot
available
approaches
advantages
limitations
production,
multiple
sources,
including
culture,
body
fluids
solid
tissues.
In
addition
presenting
latest
art
principles
research,
document
also
covers
advanced
techniques
that
are
currently
expanding
boundaries
field.
MISEV2023
includes
new
sections
on
release
uptake
a
brief
discussion
vivo
study
Compiling
feedback
ISEV
expert
task
forces
more
than
1000
researchers,
conveys
research
facilitate
robust
discoveries
move
field
forward
even
rapidly.
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Feb. 18, 2022
Abstract
Liquid
biopsy,
characterized
by
minimally
invasive
detection
through
biofluids
such
as
blood,
saliva,
and
urine,
has
emerged
a
revolutionary
strategy
for
cancer
diagnosis
prognosis
prediction.
Exosomes
are
subset
of
extracellular
vesicles
(EVs)
that
shuttle
molecular
cargoes
from
donor
cells
to
recipient
play
crucial
role
in
mediating
intercellular
communication.
Increasing
studies
suggest
exosomes
have
great
promise
serve
novel
biomarkers
liquid
since
large
quantities
enriched
body
fluids
involved
numerous
physiological
pathological
processes.
However,
the
further
clinical
application
been
greatly
restrained
lack
high-quality
separation
component
analysis
methods.
This
review
aims
provide
comprehensive
overview
on
conventional
technologies
exosome
isolation,
characterization
content
detection.
Additionally,
roles
serving
potential
biopsy
diagnosis,
treatment
monitoring,
prediction
summarized.
Finally,
prospects
challenges
applying
exosome-based
precision
medicine
evaluated.
Trends in Cell Biology,
Journal Year:
2023,
Volume and Issue:
33(8), P. 667 - 681
Published: Feb. 1, 2023
The
study
of
extracellular
vesicles
(EVs)
and
nanoparticles
(NPs)
is
rapidly
expanding
because
recent
discoveries
have
revealed
a
much
greater
complexity
diversity
than
was
appreciated
only
few
years
ago.
New
types
EVs
NPs
recently
been
described.
Proteins
nucleic
acids
previously
thought
to
be
packaged
in
exosomes
appear
more
enriched
different
two
identified
amembranous
NPs,
exomeres
supermeres.
Thus,
our
understanding
the
cell
biology
intercellular
communication
facilitated
by
release
state
flux.
In
this
review,
we
describe
highlight
advances,
present
major
outstanding
questions.
Journal of Hematology & Oncology,
Journal Year:
2020,
Volume and Issue:
13(1)
Published: Nov. 10, 2020
Abstract
Exosomes
are
a
subset
of
extracellular
vesicles
that
carry
specific
combinations
proteins,
nucleic
acids,
metabolites,
and
lipids.
Mounting
evidence
suggests
exosomes
participate
in
intercellular
communication
act
as
important
molecular
vehicles
the
regulation
numerous
physiological
pathological
processes,
including
cancer
development.
released
by
various
cell
types
under
both
normal
conditions,
they
can
be
found
multiple
bodily
fluids.
Moreover,
carrying
wide
variety
macromolecules
provide
window
into
altered
cellular
or
tissue
states.
Their
presence
biological
fluids
renders
them
an
attractive,
minimally
invasive
approach
for
liquid
biopsies
with
potential
biomarkers
diagnosis,
prediction,
surveillance.
Due
to
their
biocompatibility
low
immunogenicity
cytotoxicity,
have
clinical
applications
development
innovative
therapeutic
approaches.
Here,
we
summarize
recent
advances
technologies
exosome
isolation
research.
We
outline
functions
regulating
tumor
metastasis,
drug
resistance,
immune
modulation
context
Finally,
discuss
prospects
challenges
exosome-based
therapeutics.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Feb. 5, 2024
Abstract
Extracellular
vesicles
(EVs)
are
nano-sized,
membranous
structures
secreted
into
the
extracellular
space.
They
exhibit
diverse
sizes,
contents,
and
surface
markers
ubiquitously
released
from
cells
under
normal
pathological
conditions.
Human
serum
is
a
rich
source
of
these
EVs,
though
their
isolation
proteins
non-EV
lipid
particles
poses
challenges.
These
transport
various
cellular
components
such
as
proteins,
mRNAs,
miRNAs,
DNA,
lipids
across
distances,
influencing
numerous
physiological
events,
including
those
within
tumor
microenvironment
(TME).
Their
pivotal
roles
in
communication
make
EVs
promising
candidates
for
therapeutic
agents,
drug
delivery
systems,
disease
biomarkers.
Especially
cancer
diagnostics,
EV
detection
can
pave
way
early
identification
offers
potential
diagnostic
Moreover,
subtypes
emerging
targeted
tools,
highlighting
clinical
significance.
The
need
non-invasive
biomarkers
to
monitor
biological
processes
purposes
remains
unfulfilled.
Tapping
unique
composition
could
unlock
advanced
avenues
future.
In
this
review,
we
discuss
detail
conditions,
cancers
(encompassing
head
neck,
lung,
gastric,
breast,
hepatocellular
carcinoma),
neurodegenerative
disorders,
diabetes,
viral
infections,
autoimmune
renal
diseases,
emphasizing
advancements
molecular
diagnostics
delivery.
Advanced Science,
Journal Year:
2020,
Volume and Issue:
8(1)
Published: Nov. 27, 2020
Abstract
Extracellular
vesicles
(EVs)
are
biocompatible,
nano‐sized
secreted
containing
many
types
of
biomolecules,
including
proteins,
RNAs,
DNAs,
lipids,
and
metabolites.
Their
low
immunogenicity
ability
to
functionally
modify
recipient
cells
by
transferring
diverse
bioactive
constituents
make
them
an
excellent
candidate
for
a
next‐generation
drug
delivery
system.
Here,
the
recent
advances
in
EV
biology
emerging
strategies
bioengineering
summarized,
prospects
clinical
translation
bioengineered
EVs
challenges
be
overcome
discussed.
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Jan. 20, 2022
Primary
lung
cancer
is
one
of
the
most
common
malignant
tumors
in
China.
Approximately
60%
patients
have
distant
metastasis
at
initial
diagnosis,
so
it
necessary
to
find
new
tumor
markers
for
early
diagnosis
and
individualized
treatment.
Tumor
contribute
play
important
roles
detection
treatment,
as
well
precision
medicine,
efficacy
monitoring,
prognosis
prediction.
The
pathological
small
biopsy
specimens
determines
whether
there
are
cells
type.
Because
traumatic
compliance
with
multiple
biopsies
poor,
liquid
has
become
a
hot
research
direction.
Liquid
advantageous
because
they
nontraumatic,
easy
obtain,
reflect
overall
state
tumor,
allow
real-time
monitoring.
At
present,
mainly
include
circulating
cells,
DNA,
exosomes,
microRNA,
RNA,
platelets,
endothelial
cells.
This
review
introduces
progress
clinical
application
prospect
technology
cancer.